fund

patient

TG Therapeutics Inc

trading

Unbelievable how negative this stock trades against bio stocks with not much going on besides mediocre trials.

Big Loser Alert: Trading today&#39;s -7.2% move in TG THERAPEUTICS $TGTX https://wp.me/p5bLGB-iva5

↳ Why are you paying to be in a Trading Room?

action

$TGTX stock action negative this whole week.

$TGTX we&#39;re missing something here, the price action is a bit worrisome.

This price action is pathetic after holding this bag for years.

life

manipulation

It&#39;s eye opening to see the blatant manipulation.

$TGTX no real sellers here, all fake manipulation

Screw off $GS   hope they get crushed from the sec for stock manipulation  I can’t stand these fools.

Practically the only thing red today… lame 😒

$TGTX $19.00 in the red 😎 this thing sends chills down my arms.

Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi:

1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.

The introduction of Briumvi reduces the infusion time to one hour, shortening the patients’ time spent in a clinical setting and allowing them to enhance their quality of life.”

In pooled post hoc analyses of ULTIMATE I and II, ublituximab was associated with significant treatment benefit across multiple efficacy measures at Week 96 versus teriflunomide in participants who had not received prior DMT.

ATNM just published very good data from their P3 trail which is great news for Acute myeloid leukemia patients.

Remember that we are ultimately at the beginning of commercialization and quite possible the safest spot to be with the current facts on our superior Briumvi treatment and best pricing for market share penetration.

beyond TG doing well, and us all making a ton of profit, i genuinely hope that this is the answer a lot of MS patients need to help them navigate &amp; improve their illness.

Getting the best available treatment for the lowest price is a no brainer.

We have built what we consider to be a best-in-class team to support this launch, as well as a robust patient support program designed to aid in accessing BRIUMVI at all points through the treatment journey.

They&#39;re FDA approved, have the best in class treatment, and is more affordable than the others.

Major upgrade for patients and infusion centers

-No major health threats like breast cancer or sever liver damage like main competition

$TGTX possibly the best therapy available for MS patients that exists today!

hold

$TGTX Worthwhile hold and in time will be quite profitable.

$TGTX Please hold your shares or buy more on the dip You will be very pleased with the outcome

$TGTX good day Bulls, just hold for the gold!! !

This will be huge, and the sp for BO will be massive in 2yrs if they hold out. 100+

Buy, Accumulate, Hold…it’s common sense.

$TGTX &gt; STRONG BUY = BUY/HOLD/ACCUMULATE.

market

Chartwise,  i  would think  this  is   pretty bullish;  given  crap  market. Thoughts?

$TGTX This is the rocky Biden market u all wanted.

$TGTX market is doing good, we doing good

$TGTX Looking strong today despite the market.

TG&#39;s Briumvi is positioned to take market share because of these advantages, including how much better it is than all other competitors.

$TGTX  
I found this on NewsBreak: The stock market is on the verge of a rare bullish trifecta that suggests big upside ahead  
https://share.newsbreak.com/2tuqqt3a

I have done plenty of research lately on the market TAM and this looks primed to move quickly once it gets rolling.

$TGTX Up 23% from the lows of pre market 3 trading days ago.

Xeris Biopharma Holdings Inc

$XERS  This stock has become totally distorted by Wall Street manipulators!

In fact its just market manipulation by  shorts and rich assholes who use stocks like slot machines.

$XERS This stock is heavily MANIPULATED by a &quot;Gang of Shortsellers&quot; and has nothing to do with a fair market price!

It is so obvious this is being systematically walked down (manipulated) and has nothing to do with the Company itself, products, or the overall market.

Just goes to show how badly manipulated this is.

The manipulation of these criminals is unbelievable.

price

This Share Price is still 
 
Crazy  
 
Stupid  
 
Low. Cheers!

$XERS  This share price is crazy stupid low.

You’d think Paul would have some shame being below their price.

What is most disappointing about XERS, except for the collapse in stock price, is the failure of management to do much of anything to encourage retail or institutional investors to continue to have the confidence in management of the company or its future.

I think price targets are fake… there compensated to make targets IMO.

suck

Unfortunately, the mkt sucks now and that’s reflected in sp.

The whole market sucks and this has been unjustly hammered.

$XERS this is so fucked up its unbelievable.

Invested a lot of money , and realizing we are fucked.

What a crappy market! Hopefully next week will be better:)

$XERS A bad market must admit it is really a bad day.

$XERS A 10+ cent drop when you only have 14 of those until 0 ahead of all that gobbledygook fundamental longs are spouting is not a great sign of market confidence.

$XERS market on a year and this lame duck is flat or sinking

but unfortunately, in this market, not cheap either, and even less an outright buy without a very very strong conviction.

Market hinting something is terribly wrong with this company.

revenue

$XERS High risk is an understatement with XERS, weak drug lineup, weak pipeline, revenue grow slowing, cash burn increasing and worse than weak management should tell you to stay away.

Nothing positive, revenue continues to slow, spending increasing, generics coming, recorlev under performing and most important, incompetent management! !

Personally, I think this is very conservative, and comes in below the Strongbridge &quot;Low Case&quot; from page 87 of the merger prospectus because it comes out to $172M annual revenue in 2023 compared to $216M revenue on the prospectus.

Revenues are slowing, expenses are increasing, tech is marginal, patents will be expiring, pipeline is horrible and management is horrible.

but also very disappointing that my EV charger stocks have $Billion mkt caps with less than $50M revenue and years from cash flow positive and yet.

Not only are the current drugs low revenue producers and the pipeline is horrible.

.WS not impressed with 3 low revenue drugs and weak pipeline.

$XERS So glad I loaded up more over the past few months and mortgaged my house, wife, kids college fund, poodles and Siamese cats.

$XERS On Gvoke, &quot;better than expected growth&quot;:   
&quot;Opportunity remains huge, and you don&#39;t have to find patients.

QoQ growth would still increase by ~40% with no new patients.

Newest product Recorlev just rolled out Q1, huge potential, new best in class treatment for advanced Cushings.

Two other drugs, each growing revenue steadily.

That said, I fully expect continuing  script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.

Two (2) other drugs, each growing revenue steadily.

There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.

drug

A levothyroxine formulation that looks positive (most commonly prescribed drug) A full proven technology platform to deliver hard to administer drugs by a simple injection.

We have other amazing drugs, Recorlev, Gvoke and more including some drugs yet to be approved.

product

$XERS their primary product increases 9% week to week sales with an overall trend that&#39;s incredible.

$XERS I like their products and the inject opportunity with Horizon Tepezza is huge I wish they weren&#39;t acquired so they can keep a focus on that.

Earnings are growing and there could be great news any day from a variety of sources, whether a collab exercise of option, new product collab, royalty pmt, etc.

More important is that they grow Recorlev&#39;s revenue at high(er) speed, and continue to gain market share with Gvoke without product price drop.

Revenue exploding on the upside with
their 4 products.

Even if they have more short term gains coming soon, we know the Gvoke product will gain share back due to the more pleasant experience. Patience.

Gvoke is the best and easiest product out there.

Products have been approved and much more is coming, wait and relax.

For a tiny company like xeris to go toe to toe with lilly and grow share shows they have the best product.

$XERS Truly so strange, everything Xeris had in its programme has been met, briefly 3 FDA approved products, collaborations with major pharmacies and much, much more.

Palisade Bio Inc

management

$PALI the entire board is a scam with the baggies who were scanned by management and the whites of Wall Street

$PALI ‘s management is biggest loser of 2023.

$PALI garbage company with even worse management.

$PALI worst cheap management who doesn&#39;t know how to negotiate deal.

$PALI I blame the management as the cheaply negotiated a deal with the shorts.

Poor management got tricked by these shorts/under writers to issue a cheap offer.

Poor management doesn’t know how to negotiate a deal with new investors.

$PALI POS garbage bio with scumbag maggots for management and BOD

It’s led by shit management in the past with criminal activities without a doubt.

crash

loss

pump-and-dump

$PALI 2.41-2.25 instant algo dump..  Comical

$PALI  Another fake ass pump in the morning.

but a pump and dump crap shoot, day in and day out.

$PALI Another one that badly needs a pump.

trust

Potential 100% or more upside due to soonest low float thanks to reverse stock split approved last 04 october 2022 and massive short from hedge fund thinking to obtain 110 mil cashless warrants!

$PALI patients are in high gear 🤑🤑🤑

Conclusion: For patients undergoing elective bowel resection surgery, LB1148 was safe and well-tolerated and significantly accelerated the return of bowel function.

$PALI  $$$$$$$$$$$ in the 💰
BUY, HOLD, WAIT.

$PALI I’m telling you all .. hold and we all will bank on it .. $10

profit

$PALI Check into ✅ SHFS✅ 
Earnings around the corner with Postive EPS and net profit margin of 45%.

$PALI going to keep averaging in this bitch until I make a profit. 😂

$MULN buy some $PALI and bring profits back to $MULN 🤓

$COSM bring profits back to $pali everyone !!!

Called $PALI for 90%+ profits in a single day!

With just some volume on the positive, this one should go big.

$MULN $OPGN $PALI $IWM   Grateful for big things, small things, and every thing in between.

Think we see a big pop to the upside this week.

$PALI Miam miam good consolidation, its about to pop big not gonna lie!

$PALI I love waking up and wondering if today is the day for big winnings 🤑

but today was very very good , the gaps we&#39;re all filled nicely so This shows a nice solid uptrend with no crazy big drops.

$PALI 2 big buys at the close…something is brewing here…

This is the best scenario before a big upswing.Just be patient

$HTGM afterhours party time

$PIK ran again, no surprise stays awesome

$PALI basing hard for big pop 

$VS basing same; need absorption; will get it

$FUV could launch amazingly ⬆️

Htgm is today afterhours play idea, thin and looks ready 👀 check it imo

Top Stocks matching your search for "fund treatment"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Dec, 29, 2022

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Oct, 20, 2022

PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Jan, 1, 2023

Oct, 6, 2022

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Dec, 29, 2022

XERS

Xeris Biopharma Holdings Inc

15.52%

$1.16 - $1.34

Oct, 20, 2022

PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

Jan, 1, 2023

Oct, 6, 2022